Deutsch English Français

Contact

EP1581053

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1581053

EP1581053 - EXPRESSION OF ZETA NEGATIVE AND ZETA POSITIVE NUCLEIC ACIDS USING A DYSTROPHIN GENE [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 26.07.2013 Database last updated on 16.09.2024
Most recent event Tooltip	26.07.2013	Application deemed to be withdrawn	published on 28.08.2013 [2013/35]
Applicant(s)	For all designated states Mirus Bio Corporation 505 S. Rosa Rd. Madison, WI 53719 / US
	[2006/23]
Former [2005/40]	For all designated states Mirus Corporation 505 South Rosa Road Madison, WI 53719 / US
Inventor(s)	01 / MONAHAN, Sean, D. P.O. Box 267, 10W Hudson St. Mazomanie WI 53560 / US
	02 / WOLFF, Jon, A. 1122 University Bay Drive Madison, WI 53705 / US
	03 / SLATTUM, Paul, M. 4306 Keting Terrace Madison, WI 53711 / US
	04 / HAGSTROM, James, E. 4700 Bergamot Way Middleton, WI 53562 / US
	05 / BUDKER, Vladimir, G. 5141 Sunrise Ridge Tr. Middleton, WI 53562 / US
	06 / DAVID, B. Rozema 5731 Pembroke Drive Madison, WI 53711 / US
	[2005/47]
Former [2005/40]	01 / MONAHAN, Sean, D. 5610 Tolman Terrace Madison, WI 53711 / US
	02 / WOLFF, Jon, A. 1122 University Bay Drive Madison, WI 53705 / US
	03 / SLATTUM, Paul, M. 4306 Keting Terrace Madison, WI 53711 / US
	04 / HAGSTROM, James, E. 4700 Bergamot Way Middleton, WI 53562 / US
	05 / BUDKER, Vladimir, G. 5141 Sunrise Ridge Tr. Middleton, WI 53562 / US
	06 / DAVID, B. Rozema 5731 Pembroke Drive Madison, WI 53711 / US
Representative(s)	van Someren, Petronella F. H. M., et al Arnold & Siedsma Bezuidenhoutseweg 57 2594 AC The Hague / NL
	[N/P]
Former [2008/34]	Van Someren, Petronella F. H. M., et al Arnold & Siedsma, Sweelinkplein 1 2517 GK The Hague / NL
Former [2005/40]	Van Someren, Petronella F. H. M., et al Arnold & Siedsma, Advocaten en Octrooigemachtigden, Sweelinckplein 1 2517 GK Den Haag / NL
Application number, filing date	03743756.3	24.01.2003
	[2005/40]
	WO2003US02215
Priority number, date	US20030339934	10.01.2003 Original published format: US 339934
	[2005/40]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2004062368
	Date:	29.07.2004
	Language:	EN
	[2004/31]
	Type:	A1 Application with search report
	No.:	EP1581053
	Date:	05.10.2005
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 29.07.2004 takes the place of the publication of the European patent application.
	[2005/40]
Search report(s)	International search report - published on:	US	29.07.2004
	(Supplementary) European search report - dispatched on:	EP	22.01.2007
Classification	IPC:	A01N43/04, A61K48/00	[2007/04]
	CPC:	A61K48/0016 (EP,US); A61K48/0041 (EP,US); A61K48/0075 (EP,US); A61K48/0083 (EP,US)
	Former IPC [2005/40]	A01N43/04
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, SE, SI, SK, TR [2005/40]
Title	German:	EXPRESSION VON ZETA-NEGATIVEN UND ZETA-POSITIVEN NUKLEINSÄUREN MIT EINEM DYSTROPHIN GEN	[2005/40]
	English:	EXPRESSION OF ZETA NEGATIVE AND ZETA POSITIVE NUCLEIC ACIDS USING A DYSTROPHIN GENE	[2005/40]
	French:	EXPRESSION D'ACIDES NUCLEIQUES ZETA NEGATIFS ET ZETA POSITIFS A L'AIDE D'UN GENE DE LA DYSTROPHINE	[2005/40]
Entry into regional phase	21.05.2003	National basic fee paid
	21.05.2003	Search fee paid
	21.05.2003	Designation fee(s) paid
	21.05.2003	Examination fee paid
Examination procedure	21.05.2003	Examination requested [2005/40]
	20.08.2007	Despatch of a communication from the examining division (Time limit: M06)
	22.02.2008	Reply to a communication from the examining division
	10.02.2009	Despatch of a communication from the examining division (Time limit: M06)
	29.07.2009	Reply to a communication from the examining division
	12.01.2011	Despatch of a communication from the examining division (Time limit: M06)
	16.05.2011	Reply to a communication from the examining division
	19.10.2012	Communication of intention to grant the patent
	02.03.2013	Application deemed to be withdrawn, date of legal effect [2013/35]
	09.04.2013	Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2013/35]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 20.08.2007
Fees paid	Renewal fee
	27.01.2005	Renewal fee patent year 03
	26.01.2006	Renewal fee patent year 04
	31.01.2007	Renewal fee patent year 05
	31.01.2008	Renewal fee patent year 06
	27.01.2009	Renewal fee patent year 07
	27.01.2010	Renewal fee patent year 08
	26.01.2011	Renewal fee patent year 09
	30.01.2012	Renewal fee patent year 10
	28.01.2013	Renewal fee patent year 11
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[A]WO9955379 (MIRUS CORP [US]) [A] * page 29, line 15 - page 30, line 14 * * page 37, line 3 - line 9 * * page 39, line 2 - line 26 * * page 41, line 24 - page 43, line 6 * * page 47, line 18 - page 50, line 11 * * page 50 - page 51; table 1 * * page 51 *;
		[A]WO0074635 (MIRUS CORP [US]);
		[X]US6177403 (STEDMAN HANSELL H [US]) [X] 1-9,11-20 * column 1, line 64 - column 4, line 14 * * column 17, line 40 - column 23, line 4 * * column 28, line 4 - line 63 *;
		[A]US2001019723 (MONAHAN SEAN D [US], et al);
		[A]US2002137707 (MONAHAN SEAN D [US], et al);
		[E]WO2004062694 (MIRUS CORP [US]) [E] 1-20 * page 4, line 14 - page 7, line 27 ** page 9, line 13 - page 15, line 32 *;
		[X] - LIU F ET AL, "Transfer of full-length Dmd to the diaphragm muscle of DMD-mdx/mdx mice through systemic administration of plasmid DNA", MOLECULAR THERAPY, ACADEMIC PRESS, SAN DIEGO, CA,, US, (200107), vol. 4, no. 1, ISSN 1525-0016, pages 45 - 51, XP002970506 [X] 1-9,11-20 * page 46, column L, paragraph 2 - column R, paragraph 1 * * page 47, column L, paragraph 2 - page 48, column R, paragraph 1 * * page 50, column R, paragraphs 2,3 * DOI: http://dx.doi.org/10.1006/mthe.2001.0419
		[X] - EDITORS: BERKOW ET AL, THE MERCK MANUAL OF DIAGNOSIS AND THERAPY, FIFTEENTH EDITION, RAHWAY, N.J., USA, MERCK SHARP AND DOHME RESEARCH LABORATORIES, (1987), XP002411512 [X] 10 * page 347 - page 348 *
	International search	[A]US6177403 (STEDMAN HANSELL H [US]);
		[A]US6413942 (FELGNER PHILIP L [US], et al);
		[A] - GREELISH ET AL., "Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector", NATURE MEDICINE, (199904), vol. 5, no. 4, pages 439 - 443, XP002920731 DOI: http://dx.doi.org/10.1038/7439
		[X] - LIU ET AL., "Transfer of full-length Dmd to the diaphragm muscle of DMD-mdx/mdx mice through systemic administration of plasmid DNA", MOLECULAR THERAPY, (200107), vol. 4, no. 1, pages 45 - 51, XP002970506 DOI: http://dx.doi.org/10.1006/mthe.2001.0419

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p